ACAD

ACADIA Pharmaceuticals Inc.NASDAQHealthcare

$22.20-0.54%ClosedMarket Cap: $3.78B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-25	B of A Securities	—	Buy	—
2026-03-04	JP Morgan	—	Overweight	—
2026-02-26	RBC Capital	—	Outperform	—
2026-02-26	TD Cowen	—	Buy	—
2026-02-26	Stifel	—	Hold	—
2026-02-26	Citizens	—	Market Outperform	—
2026-02-23	Mizuho	—	Outperform	—
2026-02-06	Oppenheimer	—	Perform	—
2026-02-03	HC Wainwright & Co.	—	Buy	—
2026-01-06	Citigroup	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$0.85	$1.39B	11
Sun Dec 31	$1.57	$1.57B	14
Mon Dec 31	$1.91	$1.67B	8
Tue Dec 31	$2.60	$1.84B	12